Background
Results
IC 50 of (labelled) DOTATATE was in the nM range. Absorbed doses up to 7 Gy were obtained by 5. 2 MB213 Bi-DOTATATE, in majority the dose was caused by α-particle radiation. Cellular internalization determined with 111 In-DOTATATE showed a linear relation with incubation time. Cell survival after exposure of 213 Bi-DTPA and 213 Bi-DOTATATE to BON or CA20948 cells showed a linear-exponential relation with the absorbed dose, confirming the high LET character of 213 Bi. The survival of CA20948 after exposure to 177 Lu-DOTATATE and the reference 137 Cs irradiation showed the typical curvature of the linear-quadratic model. 10% Cell survival of CA20948 was reached at 3 Gy with 213 Bi-DOTATATE, a factor 6 lower than the 18 Gy found for 177 Lu-DOTATATE and also below the 5 Gy after 137 Cs external exposure. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
The receptor-mediated endocytosis pathway is one of the main pathways to deliver biomolecules in cells. Peptide receptor radionuclide therapy (PRRT) uses this process to deliver cytotoxic dose by the emission of β-particles to neuroendocrine tumours (NET). Somatostatin peptide analogues, such as DOTA-DPhe Lu (T 1/2 = 6.6 d), high radiation doses can be delivered to tumour cells, causing mostly single-strand breaks (SSB) in the DNA of the tumour cells. Dependent on the number of SSB, cells can undergo cell arrest, with either activation of the cellular repair mechanism for repair or apoptosis as a consequence [1] . Combination of several repairable SSB lesions may lead to additional cell kill.
α-Emitters (e.g. Bi-peptides have already been proven to be promising in PRRT with NETs in preclinical as well in clinical studies [2] [3] [4] [5] . α-Emitters emit high LET particles, causing double-strand breaks (DSB) in DNA when targeted to the tumour cells [6] . Therefore, the cytotoxic property in cells is found to be greater for α-emitters than for β-emitters [6, 7] .
The cytotoxic response of the cells is related to the absorbed dose delivered to the cells. Several studies have been investigating the absorbed dose caused in cells by α-emitters [8] [9] [10] . Those studies showed the challenge involved in describing dose-related survival in cells with α-particles radiation. Huang and co-workers distinguished three clear differences in cell dosimetry calculations for α-emitters compared to β-emitters or to external beam therapy; 1) short path length, 2) small target volume and 3) non-uniform distribution of radionuclides [11] . For β-emitters and external γ-beams, hundreds to thousands of ionizations are required for a cell-killing effect, whereas using α-emitters, this can be reached with 4-10 ionizations. Due to the low number of ionizations, leading to large variations in the number of α-particle tracks traversing the cells, the validity of the mean absorbed dose which assumes Poisson statistics, was not always given for α-emitters [12] . Moreover, variability in experiments strongly influenced the calculated absorbed dose, for example the models in which the absorbed dose was calculated; single cells, clusters of cells or whole organs. Furthermore, inhomogeneous uptake can also influence the calculated absorbed dose. The dose limits for α-emitters showed a high model dependence for selected survival endpoints, and therefore, the relative biological effect (RBE) should be considered within the same model and using the same endpoint. As mentioned, the calculation of the absorbed dose in vitro for α-emitters can be quite complicated. Many studies only mention the radioactivity administered to the cells instead of using absorbed dose. Therefore, the effective cytotoxic properties of α-emitters as published cannot easily be compared to each other on an absorbed dose level.
In this study we calculated the average absorbed dose delivered to single cells using nonspecific and receptor-specific binding absorbed dose calculation methods. The non-specific binding method describes the homogeneous irradiation from medium without specific binding of labelled peptide to the receptors on the cell, whereas the specific binding method describes the specific binding of the labelled peptide to the receptor on the cell and the addition of homogeneous irradiation from medium to the cells. Affinity studies in K562-SSTR 2 (transgenic human erythroleukemic cells transfected with somatostatin receptor subtype 2 (SSTR 2 )) cells were performed to determine the IC 50 of DOTATATE, 115 In-DOTATATE,
175
Lu-DOTATATE, and 209 Bi-DOTATATE. An internalization assay with CA20948 (rat pancreatic tumour) cell using 111
In-DOTATATE was performed to obtain information of the kinetics of cell uptake. Based on results obtained from cell uptake, small-scale dosimetry calculations were performed to provide the additional absorbed dose caused by specific binding to the cells to obtain the correlation between absorbed dose and cell survival. We evaluated the RBE at the absorbed dose of 10% survival (D 10 ) of 213 Bi-DTPA, 213 Bi-DOTATATE, 177 Lu-DTPA, 177 Lu-DOTATATE and external radiation using 137 Cs using two different cell lines;
CA20948 [13] with high and BON (human carcinoid) with low SSTR 2 expression [14] . The aim of the study was to compare the effective cytotoxic properties of different irradiation methods i.e. external photon irradiation and targeted radionuclide therapy in the same study.
Materials and methods
All chemicals were purchased from Sigma Aldrich, culture media for cell culture and in vitro assays were purchased from Gibco, Life Technologies, unless otherwise indicated. Bi containing elution was added to a mixture of 7 nmol DOTATATE, 60 μL TRIS 2M, 1.85 μL ascorbic acid 20% and MQ (final volume 800 μL). The reaction was performed at 95˚C for 5 min and cooled on ice for 2 min afterwards. 5 μL of DTPA 10 mM was added to stop the labelling and chelate "unbound"/"free" 213 Bi [18] .
Cell culture
To determine the incorporation of the radioactivity, ITLC (Instant Thin-Layer Chromatography) was performed after each labelling. HPLC (High Performance Liquid Chromatography) was performed to determine the radiochemical purity (RCP) of the radiopeptides as described by the Blois et al. [19] . RCP of the labelled peptide was expressed as percentage of intact labelled peptide of interest versus of all other radioactive detectable compounds. -octreotide using chloramine-T as described elsewhere [20] . Analysis and purification of the radioiodinated peptide were performed using HPLC as described by de Blois et al [19] .
Labelling of non-radio-peptide
The labelling of 115 In-DOTATATE was performed by addition of 115 InHNO 3 (ICP standard, 1 g/L) to DOTATATE at a molar ratio of 5:1. The pH was adjusted to a pH of 4 by adding sodium acetate (2.5 M) and the labelling mixture was heated for 30 min at 80˚C. Quality control was performed using HPLC as described previously [19] . UV-detection was performed at 278 nm. Under these conditions, DOTATATE was fully incorporated with 115 In. After quality control the labelled peptide was purified and collected using the same HPLC method. The concentration of the labelled peptide was determined by UV spectrophotometer at 278 nm. This procedure was also performed for the labelling of 
IC 50
IC 50 values of DOTATATE, 115 In-DOTATATE, 175 Lu-DOTATATE or 209 Bi-DOTATATE were determined using K562-SST 2 membranes [21] . In short, cell membranes were isolated as described by Reubi [22] . Freshly dispersed membrane preparations (corresponding to 25 μg protein) were incubated at room temperature for 60 min with Bi-DOTATATE in HEPES buffer (10 mM HEPES, 5mM MgCl 2 and 0.02 g/L bacitracin pH 7.6) containing 0.2% BSA. After incubation for 1 h, 1 mL HEPES (4˚C) was added to stop the reaction. Non-bound radioligand was separated from the membrane-bound radioligand by centrifugation for 2 min at 10000 g. The remaining pellet was washed twice with ice-cold HEPES buffer and counted in a γ-counter (Wallac Wizard 3, Perkin Elmer, Groningen, the Netherlands) [21] . One-way ANOVA was used to calculate significant differences of IC 50 In-DOTATATE, ranging from 1 nM to 390 nM, for 1 h at 37˚C. After incubation 111
In-DOTATATE was removed from the cells by washing the cells twice with 1 mL ice-cold PBS. Ice-cold strip medium (1mL, HBSS containing 20 mM sodium acetate, pH 5) was added to the cells and incubated for 10 min to remove membranebound (ƒ mem ) 111 In-DOTATATE from the receptor. The strip medium was collected and 1 mL of ice-cold strip medium was added to the cells for 10 min incubation and collected again. Sodium hydroxide (1mL, 1M) was added to the cells to detach the cells from the well and to determine the radioactivity inside the cells, this is the internalized fraction (ƒ int ). The ƒ int was collected separately from the ƒ mem . The collected fractions were measured by the γ-counter. The results were plotted as % activity (%A) compared to total applied activity. To determine the non-specific binding, an excess of DOTATATE (1x10 Bi-DOTATATE. Before irradiation of the cells, 500 cells were seeded in 6-well plates (pre-coated with poly-l-lysine) 24 h before the experiment. The cells were treated with increasing doses of radioligand, diluted in internalization medium (30 mM HEPES and 0.25% BSA), and incubated for 1 h at 37˚C in a humidified atmosphere of 5% CO 2 . After irradiation, internalization medium containing radioligand was removed. Cells were washed twice with PBS and incubated with medium containing 10% FBS for 12 d. Every 2 or 3 d, medium was replaced by fresh culture medium. In order to be able to compare the cytotoxic effect of After incubation over a period of 12 days at 37˚C in a humidified atmosphere of 5% CO 2 , cells were washed twice with PBS, fixed with 1 mL 100% ethanol and stained with 1 mL hematoxylin. The 6-well plates containing colonies were scanned with a HP-scanner at 200 dpi. The colonies in each well were counted by a clonocounter [23] . The survival was plotted as a function of absorbed dose and fitted to linear-quadratic (LQ) or linear-exponential curves.
Non-specific binding absorbed dose
The cell absorbed dose during the incubation period was calculated with a dosimetry model of the 6-well plate, as described by Verwijnen et al. [24] . The 3.5 cm diameter well cavity was modeled in the Monte Carlo radiation transport code Monte Carlo N-Particle eXtended MCNPX (version 2.5.0, Los Alamos National Laboratory, USA) with homogeneously distributed radioactivity over the 2 mL volume aqueous liquid within the cavity. Dose scoring regions of 25 μm were used to calculate the absorbed fractions of energy as a function of depth in the bottom 200 μm of the well, see Fig 1. The division the layers of the well were as followed; 18 layers of 100 μm and 8 layers of 25 μm at the bottom of the well.
The lowest layer of 25 μm was used for the calculation of absorbed dose at the bottom of the well containing 500 cells.
Radiation energy spectra for 177 Lu,
213
Bi and its daughters were derived from the MIRD radionuclide data handbook [25] . For each emission (α-, β-particles, low energy Auger-and internal conversion electrons and γ-rays) 10 million particle histories were used for particle transport calculations in MCNPX. Absorbed energy was calculated in the dose scoring regions within the cavity filled with radioactivity and the cross dose to the other 5 well cavities. Absorbed dose rates per unit activity (or S-values) for each radionuclide and dose scoring region were calculated following the MIRD schema [26] .
The cells in the clonogenic assay were assumed to lie on the bottom surface of the 6-well plate cavities and therefore the macroscopic mean absorbed dose D to the cells during the 1 h incubation was calculated from the S-value in the bottom 25 μm layer and the time-integrated activity Ã by:
Dð25mm
fluidÞ ¼ e A fluid ð1Þ Â Sð25mm fluidÞ ¼
A fluid e À lt dt Â Sð25mm fluidÞ
The integration was performed for the activity in the fluid from T 0 = 0 to T = 1 h, also taking into account the progeny activity from 213 Bi together with their specific S-values. The contributions to the absorbed dose by α-particles were considered separately from the dose by β-particles, low energy electrons and γ-rays.
Specific binding absorbed dose
For cell dosimetry calculation, the total uptake (ƒ mem and ƒ int ) of 0.5x10 6 cells (CA20948) was extrapolated to the uptake of 500 cells. The percentage of uptake was then used for cell dosimetry with the assumption that the radioactivity was bound to the cell membrane (f int = 0 and f mem = 1) over a period of 12 d without dissociation of the radioactivity. The dosimetry for the specific uptake of radioactivity in the cells was calculated with the multicellular dosimetry code MIRD cell [27] . For the calculation of dosimetry in CA20948, a cell radius of 6 μm was taken, as the uptake in the cells was not further differentiated, only uptake on the cell surface and homogeneous cell uptake were considered. Initially 500 cells were plated over the 9.62 cm 2 surface of the well. For evenly distributed cells over the surface the mean inter-cell distance would be 770 μm. In reality the cells were more clustered to the center of the well. Furthermore, the inter-cell distance was larger than the range of the α-particles and hence the cross-dose contribution from radioactivity taken up in neighboring cells was assumed to be minimal. Lu in the cell or on the surface of a spherical cell with a radius of 6 μm. Also the cross-dose S-values for cells with radioactivity at 50 μm and at 100 μm are indicated.
The mean self-absorbed dose to the cells was calculated by the product of Ã cell the mean cumulated activity per cell with the cellular S-values specific for the binding site: 
The integration over time was performed between T 0 = 1 h and T = 12 d. It was assumed that no radioligand cleared from the cells once it was bound. The absorbed dose originating from the cellular uptake during the 1 h incubation period was neglected.
Results

Labelling
The incorporation for all used radiolabelled peptide was >99% and the RCP of 111 In-DOTA- Bi-DOTATATE showed similar affinities to SSTR 2 on the membranes of K562-SST 2 cells. Lu for a cell with a radius of 6 μm according to MIRDcell code. 
Self-dose Cross-dose S(C C') S(C C) S (C CS)
Internalization in SSTR 2 positive CA20948 cell line
Internalization was performed to determine the amount of radioligand bound to the receptors, at the cell membrane and internalized into the cell. Optimized concentration of 111
In-DOTA-TATE for internalization on CA20948 was 1 nM. At this concentration, the f int increased linearly as a function of incubation time. However, the f mem remained constant at a level of 0.008%A as a function of incubation time, see Fig 2. The lines indicate the fitted curves with the 95% confidence intervals, internalization data linear curve (R 2 = 0.97) with slope: 0.096 ± 0.003%IA/min and for the f mem the mean value of 0.56 ± 0.06%IA.
Binding assays with 213
Bi-DOTATATE involved high concentrations of unlabelled peptide due to the low molar activity of labelled peptide. At the highest peptide amount used for the In-DOTATATE as a surrogate to study the uptake kinetics with the concentration used in the clonogenic assay. Cells were incubated with decreasing concentrations of peptide (ranging 390 to 15 nM) for 1 h. The uptake was found to be relatively low, the ƒ mem and ƒ int were difficult to distinguish from each other, and therefore the sum of ƒ mem and ƒ int was used for further cell dosimetry calculations, see Fig 3A. The uptake was used to calculate the number labelled peptide, 
Clonogenic assay of BON and CA20948 cells using external irradiation
The survival of BON and CA20948 cells after exposure to escalating absorbed doses with a 137 Cs source is showed in Fig 4. Up to absorbed doses of 4 Gy similar survival curves were found for both cell lines. At absorbed doses above 4 Gy, CA20948 showed to be more radioresistant than BON, see Table 2 . Curves according to the LQ model were fitted with high correlation coefficients (R 2 = 0.98 and 0.93, respectively), indicating that the curvature of the BON cells was more profound than for CA20948.
Dosimetry
The time-integrated activity coefficient in the well cavity during the 1 h incubation period was 2361 MBq.s per MBq
213
Bi, leading to an absorbed dose of 1.60 Gy/MBq in the 2 mL fluid and 1.12 Gy/MBq in the bottom 25 μm layer. The absorbed dose was delivered 96.2% by the α-particles, see Table 3 .
Clonogenic assay of BON and CA20948 cells using radiolabelled ligand BON and CA20948 cells were treated with increasing amounts of radioactivity coupled to the radioligand; Bi-DOTA-TATE, 177 Lu-DOTATATE irradiation for BON and CA20948 are shown in Table 4 .
Discussion
In this study we selected DOTATATE as a targeting ligand. To investigate the distribution, time-dependent and peptide amount-dependent uptake, DOTATATE was labelled with the γ-emitting radionuclide 111 In. The results obtained were used for further cell averaged dosimetry. The effect on cell survival caused by radiation was compared using β-emitting parameter for the success of peptide receptor radionuclide therapy due to receptor-mediated process, therefore a high and a low SSTR 2 expression cell line were chosen here, to compare the receptor-dependent-survival. Cell averaged dosimetry was performed. The activity uptake in the cells was analyzed for 500 cells and the high LET character of the individual α-particle tracks were averaged out for dosimetry calculation. 111 In-DOTATATE,
177
Lu-DOTATATE,
213
Bi-DOTATATE and DOTATATE were shown to have similar affinity for SSTR 2 . IC 50 values were similar of labelled peptides i.e. in the nM Bi-DOTATATE molecules were bound per cell with the highest radioactivity amount used for clonogenic assay. This is low in comparison to the 44000±8000 177 Lu-DOTATATE molecules at the same peptide amount, but still high enough to warrant average cellular dosimetry.
In this study we found that the highest cytotoxic effect was caused by 213 Bi-ligands. The theoretical advantage of using α-emitters as therapeutic agents is the independence of dose rate, oxygenation and cell proliferation [28, 29] . Cytotoxic effects caused by 213 Bi-DOTATATE demonstrated no discrimination between cell types and level of SSTR 2 expression. We observed a similar cytotoxic effect with 213 Bi-DTPA and 213 Bi-DOTATATE in CA20948, indicating a cytotoxic dose can be delivered to the cells in vitro without specific binding and peptide receptor-mediated endocytosis. The low MA of the labelled peptide led to rapid saturation of the receptors by unlabelled peptides thereby causing a higher concentration of labelled peptide in the incubation medium. The effect and absorbed dose by the specific binding was therefore reduced in comparison to the contribution by the medium. The absorbed dose during incubation of the cells, which is independent of specific uptake, forms the main contribution to the total dose, 53-76% depending on the amount of activity. The absorbed dose by the specific binding fraction can be increased to levels similar to the dose contribution from the medium exposure by using activities > 10 MBq. This would correspond to a minimal requirement of a 225 Ac generator twice the activity used in the current experiments (222 MBq). Furthermore, the irradiation time can then be reduced to 30 min.
In our study the D 10 in BON was 4. Bi-DOTATATE, MA (Bq/nmol) on the cell played a significant role here, the number of DNA hits appeared to be insufficient to influence cell survival. Heterogeneous distribution can influence the amount of ionizations traversing to the DNA of the cell causing irreparable DBS, as described by Pasternak et al (9) . The advantage of increasing the MA of labelled antibodies by an antibody cocktail caused a more homogenous binding to the cells and increased the cell-killing ability of α-emitters [9] . Lu-DOTATATE (0.33 MBq, lowest radioactivity used to treat cells) to CA20948 resulted in an absorbed dose at least 7 times higher than without specific binding ( 177 Lu-DTPA). In our study, only 500 cells were plated in the well for the clonogenic assay and were assumed to be spherical in shape with a diameter of 12 μm and homogenously distributed on the bottom of the well. The average distance between homogeneously distributed cells was approximately 1500 μm. The maximum path length in tissue for α-particle is 50-100 μm and for β-particle is 1-10 mm. Absorbed dose by cross-fire contributed from Gy with a distance of the 1500 μm [31] . As for 213 Bi-DOTATATE, the maximum path length of 213 Bi is 80 μm and the distance between the cells was >1500 μm, an additional dose to the calculated absorbed dose caused by cross-fire effect was not taken into account. Despite this we assumed that the cells were homogeneous distributed, as clustering of cells can still occur, leading to an increase of the absorbed dose caused by cross-fire effect of neighboring cells. This was often observed in studies using low energy β-particles such as
